22 /100
LOW RISK
Score updated Jul 13, 2026

PBYI — Puma Biotechnology, Inc. Dilution Risk Tracker

Track PBYI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PBYI — Get alerts when the score changes →

As of July 13, 2026, Puma Biotechnology, Inc. (PBYI) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. Puma Biotechnology, Inc. has a market capitalization of $364.95M, 50.90M shares outstanding, 158 institutional holders tracked. Key dilution vectors include 2.12M outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PBYI.
🔔 Track PBYI — Get forecast alerts →

💹 Market Data

Market Cap$364.95M
Shares Outstanding50.90M
Float39.09M
Cash$101.55M
Debt$11.28M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 16.6% shares (2026Q1 vs prior)
158 institutional holders · 41.95M shares
#1 ACORN CAPITAL ADVISORS, LLC 4.13M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.64M shares
#3 BlackRock, Inc. 3.60M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.63M
Days to Cover8.5
% of Float9.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2013
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PBYI Shareholders

Puma Biotechnology, Inc. (PBYI) has a DilutionScore of 22/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 2.1M outstanding warrants for PBYI. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for PBYI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PBYI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track PBYI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PBYI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PBYI
📊 PBYI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PBYI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.